Posts Tagged: Centre for Commercialization of Regenerative Medicine (CCRM)

Federal government awards the University of Toronto $114-million regenerative medicine grant

On Tuesday, July 28, 2015, the federal government announced a $114-million grant to cement the University of Toronto's position as one of the world's leading centres for the design and manufacture of cells, tissues and organs to treat degenerative disease. This announcement was covered in The Globe & Mail and Lab Products News, and by CBC.ca, CTV News and Global TV. MaRS Innovation was specifically mentioned as a commercialization partner in the Toronto Star's coverage. As the university's commercialization agent, MaRS Innovation welcomes this ... Read more

Accel-Rx, the national health sciences accelerator, launches as a Centre of Excellence for Commercialization and Research (CECR)

MaRS Innovation among founding partner CECRs; Accel-Rx will provide funds to new biotechnology start-ups emerging within MI's portfolio VANCOUVER, BC (Aug. 25, 2014) –With the awarding of $14.5M under the Canadian government’s Networks of Centres of Excellence (Centres of Excellence for Commercialization and Research (CECR)) Program, as announced earlier this morning by the Honourable Ed Holder, Minister of State for Science and Technology, Accel-Rx - Canada’s Health Sciences Accelerator is officially launched. Media coverage of this announcement: CBC's Inside Politics blog, IT Business ... Read more

Accel-Rx Health Sciences Accelerator to Partner with BDC Venture Capital

MaRS Innovation co-partner in pan-Canadian effort to help create up to 20 leading start-up companies CEBIO International Conference, San Diego – June 25, 2014: BDC Venture Capital and the Accel-Rx Health Sciences Accelerator (Accel-Rx) announced today a collaboration to provide critical seed funding to new and emerging Canadian health sciences companies. This announcement was covered in TechVibes, PE HUB and BetaKit. Together, Accel-Rx, BDC Venture Capital, and CDRD Ventures Inc. (CVI) which will provide the initial management to launch Accel-Rx operations, would focus on ... Read more

Four professors working with MaRS Innovation among U of T’s Inventors of the Year

Four University of Toronto (U of T) professors who have commercialization projects in various stages with MaRS Innovation were named to the university's list of Inventors of the Year. “The Inventor of the Year Award is meant to recognize inventions that have the potential to improve our quality of life,” said Professor Paul Young, vice-president (research and innovation) and a member of MaRS Innovation's Board of Directors. “The winning inventions represent the very best of innovation at U of T, and on ... Read more

Biotechnology Focus’ December issue covers MaRS Innovation projects and partnerships

MaRS Innovation's (MI) projects and partnerships earned three separate article mentions in the December 2012 issue of Biotechnology Focus, including: MI and UHN's partnership with Stem Cell Therapeutics was covered in the magazine's Dealmakers subsection. Read the write-up on the Biotechnology Focus website. Cellax, a licensable technology that may produce a nanotechonology-based cancer drug, was highlighted in the magazine's Business Corner section (read the write-up). Cellax is a joint project between MI and the Ontario Institute for Cancer Research. MaRS Innovation's ... Read more

University of Toronto: Snapshot of Toronto’s Entrepreneurship Scene

The University of Toronto's news site has posted a brief snapshot of Toronto's entrepreneurial scene, highlighting the university's historical and current innovative strengths. Here's a brief excerpt: Entrepreneurs don’t have to be in Silicon Valley to become the next great business success story. Toronto now ranks fourth among the world’s top 25 start-up ecosystems, according to Start-up Genome, a project that maps the success rates of start-ups. Toronto ranks just behind Silicon Valley, New York City and London. (more…) Read more

$15M Funding announcement for CCRM

As part of MaRS Innovation's strategy to bundle technologies, our first initiative focused on regenerative medicine and creating the Centre for Commercialization of Regenerative Medicine (CCRM) located in Toronto, Ontario. We are pleased that these efforts have been recognized by the Government of Canada's National Centres of Excellence (NCE) program, which recently announced a $15 million funding grant for CCRM through the Centres of Excellence for Commercialization and Research. (more…) Read more